{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:58:26Z","timestamp":1769072306760,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404054"],"award-info":[{"award-number":["82404054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The accurate differentiation of thymic masses, particularly thymic carcinoma (TC), is imperative for guiding optimal treatment selection. This study investigated potential non-invasive biomarkers for discerning thymic malignancies and evaluated their clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinicopathological data from 1897 patients who underwent surgical resection for thymic masses across 2 institutions were retrospectively analysed. Associations between serum tumour markers and TC diagnosis were assessed using the area under the receiver operating characteristic curve (AUC). The clinical utility of the identified tumour markers was further evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the discovery cohort from Shanghai Pulmonary Hospital (SPH), cytokeratin 19 fragment antigen 21-1 (CYFRA 21-1) levels were significantly higher in the TC group compared to both the thymoma group and the non-thymic epithelial tumour (non-TET) group (median of 2.38 ng\/mL vs 1.39 ng\/mL or 1.28 ng\/mL, both P\u2009&amp;lt;\u2009.001), with AUC value of 0.778 (95% CI: 0.735-0.822) compared to thymoma and 0.808 (95% CI: 0.766-0.849) compared to non-TET group. Validation in the cohort from Renmin Hospital of Wuhan University further demonstrated significant discrimination of CYFRA 21-1 for TC diagnosis (vs thymoma: AUC\u2009=\u20090.681 [95% CI: 0.518-0.843]; vs non-TET: AUC\u2009=\u20090.801 [95% CI: 0.622-0.980]). Furthermore, high CYFRA 21-1 levels were also correlated with a shorter median disease-free survival compared to the low CYFRA 21-1 group (10.0 years vs 14.9 years, P\u2009&amp;lt;\u2009.001) in patients with TET in the SPH cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CYFRA 21-1 emerges as a reliable diagnostic biomarker for distinguishing TC from other thymic masses. Moreover, it holds promise for prognosis evaluation and potentially for recurrence surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejcts\/ezag017","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:42:23Z","timestamp":1767876143000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum Cytokeratin 19 Fragment Antigen 21-1 as a Diagnostic and Prognostic Biomarker for Thymic Carcinoma in Thymic Masses"],"prefix":"10.1093","volume":"68","author":[{"given":"Ziyun","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tieyuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Renmin Hospital of Wuhan University , Wuhan, 430060,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinsheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixin","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-7545","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University , Shanghai, 200433,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026012003521132900_ezag017-B1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026012003521132900_ezag017-B2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ejca.2012.02.047","article-title":"Rare thoracic cancers, including peritoneum mesothelioma","volume":"48","author":"Siesling","year":"2012","journal-title":"Eur J Cancer"},{"key":"2026012003521132900_ezag017-B3","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026012003521132900_ezag017-B4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2026012003521132900_ezag017-B5","doi-asserted-by":"publisher","first-page":"102014","DOI":"10.1016\/j.ctrv.2020.102014","article-title":"Thymic epithelial tumors: from biology to treatment","volume":"86","author":"Conforti","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"2026012003521132900_ezag017-B6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ejcts\/ezv239","article-title":"Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese nationwide database study","volume":"49","author":"Hishida","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012003521132900_ezag017-B7","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1007\/s00330-019-06080-4","article-title":"Predicting pathological subtypes and stages of thymic epithelial tumors using DWI: value of combining ADC and texture parameters","volume":"29","author":"Li","year":"2019","journal-title":"Eur Radiol"},{"key":"2026012003521132900_ezag017-B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40644-023-00617-z","article-title":"Histogram analysis based on unenhanced CT for identifying thymoma and lymphoma among prevascular mediastinal incidentalomas","volume":"24","author":"Liu","year":"2024","journal-title":"Cancer Imaging"},{"key":"2026012003521132900_ezag017-B9","doi-asserted-by":"publisher","first-page":"20180598","DOI":"10.1259\/bjr.20180598","article-title":"Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma","volume":"92","author":"Xie","year":"2019","journal-title":"Br J Radiol"},{"key":"2026012003521132900_ezag017-B10","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/jmri.22377","article-title":"Computed tomography and magnetic resonance imaging of mediastinal tumors","volume":"32","author":"Takahashi","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"2026012003521132900_ezag017-B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12880-023-01185-1","article-title":"A diagnostic model based on (18)F-FDG PET\/CT parameters in improving the differential diagnosis of invasive thymic epithelial tumors and anterior mediastinal lymphomas","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Med Imaging"},{"key":"2026012003521132900_ezag017-B12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.lungcan.2014.08.008","article-title":"Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis","volume":"86","author":"Treglia","year":"2014","journal-title":"Lung Cancer"},{"key":"2026012003521132900_ezag017-B13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1245\/s10434-023-14328-z","article-title":"Impact of (18)F-FDG PET on TNM staging and prognosis in thymic epithelial tumors","volume":"31","author":"Akamine","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026012003521132900_ezag017-B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejrad.2006.05.003","article-title":"Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas","volume":"60","author":"Sadohara","year":"2006","journal-title":"Eur J Radiol"},{"key":"2026012003521132900_ezag017-B15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.hoc.2008.03.011","article-title":"Imaging of thymic epithelial neoplasms","volume":"22","author":"Rosado-de-Christenson","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"2026012003521132900_ezag017-B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thorsurg.2010.08.008","article-title":"Prediction of thymoma histology and stage by radiographic criteria","volume":"21","author":"Yanagawa","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"2026012003521132900_ezag017-B17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jtcvs.2022.02.055","article-title":"Positron emission tomography\/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma","volume":"165","author":"Byrd","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012003521132900_ezag017-B18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ejcts.2009.03.055","article-title":"Role of fluorine-flurodeoxyglucose positron emission tomography\/computed tomography in preoperative assessment of anterior mediastinal masses","volume":"36","author":"Luzzi","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012003521132900_ezag017-B19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.hoc.2008.03.002","article-title":"Thymic carcinoma: current concepts and histologic features","volume":"22","author":"Moran","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"2026012003521132900_ezag017-B20","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41467-020-18697-x","article-title":"Interleukin-8 as a candidate for thymoma identification and recurrence surveillance","volume":"11","author":"Gao","year":"2020","journal-title":"Nat Commun"},{"key":"2026012003521132900_ezag017-B21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1097-0142(19930801)72:3&lt;707::aid-cncr2820720313&gt;3.0.co;2-x","article-title":"CYFRA 21-1. A new marker in lung cancer","volume":"72","author":"Stieber","year":"1993","journal-title":"Cancer"},{"key":"2026012003521132900_ezag017-B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12967-019-1828-0","article-title":"The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to nivolumab in advanced non-small cell lung cancer (NSCLC) patients","volume":"17","author":"Dal Bello","year":"2019","journal-title":"J Transl Med"},{"key":"2026012003521132900_ezag017-B23","doi-asserted-by":"publisher","first-page":"e182078","DOI":"10.1001\/jamaoncol.2018.2078","article-title":"Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins","volume":"4","author":"Guida","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026012003521132900_ezag017-B24","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1164\/rccm.202012-4438OC","article-title":"Integrated biomarkers for the management of indeterminate pulmonary nodules","volume":"204","author":"Kammer","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012003521132900_ezag017-B25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1164\/rccm.202107-1769OC","article-title":"CYFRA 21-1 predicts progression in idiopathic pulmonary fibrosis: a prospective longitudinal analysis of the PROFILE cohort","volume":"205","author":"Molyneaux","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012003521132900_ezag017-B26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/resp.13988","article-title":"Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression","volume":"26","author":"Stock","year":"2021","journal-title":"Respirology"},{"key":"2026012003521132900_ezag017-B27","doi-asserted-by":"publisher","first-page":"AB010","DOI":"10.21037\/med-22-ab010","article-title":"AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors","volume":"6","author":"Hao","year":"2022","journal-title":"Mediastinum."},{"key":"2026012003521132900_ezag017-B28","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1111\/1759-7714.14158","article-title":"Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma","volume":"12","author":"Shiiya","year":"2021","journal-title":"Thorac Cancer"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezag017\/66327142\/ezag017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezag017\/66327142\/ezag017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezag017\/66327142\/ezag017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:52:17Z","timestamp":1768899137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezag017\/8418387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezag017","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"ezag017"}}